Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Cost of Revenue (2009)

Updated

Kazia Therapeutics' Cost of Revenue came in at $1.88 million for FY2010 (year ended Jun 30, 2010).

Analysis

Kazia Therapeutics (KZIA) Cost of Revenue (2009) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Cost of Revenue at $2 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 8.10 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 4.29 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.57 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.03 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 791,697.28
API Access

Kazia Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KZIA&period=max&api_key=YOUR_API_KEY